Yifeng Capital

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 1, 2023	Raynovent	$53.5M Series C	Huang Qingshan, Jinqiao Zhu	Yang Xi, Qingchi Capital, Wanlian Guangsheng, Zhongsheng Ruichuang Biotechnology
Mar 4, 2021	Gensciences	$123.6M Series A	—	Haoyue Hu, Lianxin Capital

Total Raised

N/A

Valuation

N/A